Clinical Trials Browser

Terminated × Urethral Neoplasms × Sorafenib × Clear all

NCT00112905 2014-05-30

Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Phase 2 Terminated

27 enrolled 8 charts

Urinary Bladder Neoplasms, Urethral Neoplasms